Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$93.66 - $139.27 $163,062 - $242,469
-1,741 Closed
0 $0
Q1 2021

Apr 12, 2021

SELL
$116.57 - $155.01 $14,454 - $19,221
-124 Reduced 6.65%
1,741 $229,000
Q4 2020

Feb 11, 2021

BUY
$99.61 - $142.12 $156,288 - $222,986
1,569 Added 530.07%
1,865 $247,000
Q3 2020

Oct 28, 2020

SELL
$72.92 - $102.01 $1,093 - $1,530
-15 Reduced 4.82%
296 $30,000
Q2 2020

Jul 20, 2020

SELL
$55.75 - $92.75 $7,247 - $12,057
-130 Reduced 29.48%
311 $27,000
Q1 2020

Apr 13, 2020

SELL
$37.9 - $104.44 $75 - $208
-2 Reduced 0.45%
441 $29,000
Q4 2019

Jan 24, 2020

BUY
$77.66 - $99.74 $20,890 - $26,830
269 Added 154.6%
443 $41,000
Q3 2019

Oct 15, 2019

SELL
$90.37 - $122.49 $813 - $1,102
-9 Reduced 4.92%
174 $16,000
Q2 2019

Jul 10, 2019

SELL
$89.51 - $118.04 $537 - $708
-6 Reduced 3.17%
183 $22,000
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $7,002 - $8,905
189
189 $9,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.